NHSc offers an extensive consumer health portfolio of industry-leading medical nutrition, consumer, and VMS brands. This deal will expand their coverage while simultaneously increasing the services that they provide. While commenting on the acquisition, Greg Behar, CEO of Nestlé Health Science, said: IM HealthScience (IMH) is the innovator of FDgard and IBgard for the dietary management of FD (Functional Dyspepsia) and IBS (Irritable Bowel Syndrome), respectively. The privately held firm based in Boca Raton, Florida was founded in 2013 by highly experienced pharmaceutical research and development and management executives. The company mainly targets conditions that have a high rate of unmet medical needs. Some of the areas that they cover include gastrointestinal health, acute care, oncology, pediatric health, allergy, metabolic health, healthy aging, and inborn errors of metabolism. The chairman and founder of IM HealthScience, Fred Hassan, commented on the acquisition by Nestlé: Fiber Choice joined IMH in 2017 through an acquisition. Fiber Choice specializes in prebiotic fibers. On the other hand, REMfresh is a renowned continuous release-and-absorption melatonin (CRA-melatonin) supplement manufactured for sleep.
